Accomplished pharmaceutical R&D leader with over 15 years of experience in formulation development, modified-release technologies, and fixed-dose combination (FDC) products. Proven track record in leading multi-disciplinary teams, securing government-funded research grants, and executing successful technology transfers with global and domestic pharmaceutical partners. Recognized for expertise in BE/PK study design, IND/CTD dossier preparation, and regulatory strategy. A visionary leader driving innovation through strategic planning, drug repositioning, and cross-functional collaboration.